0001055726-19-000017.txt : 20190312 0001055726-19-000017.hdr.sgml : 20190312 20190312191844 ACCESSION NUMBER: 0001055726-19-000017 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190308 FILED AS OF DATE: 20190312 DATE AS OF CHANGE: 20190312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Humeau Laurent CENTRAL INDEX KEY: 0001770390 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14888 FILM NUMBER: 19676492 MAIL ADDRESS: STREET 1: C/O INOVIO PHARMACEUTICALS, INC. STREET 2: 660 W. GERMANTOWN PIKE, SUITE 110 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001055726 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330969592 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584103134 MAIL ADDRESS: STREET 1: 6769 MESA RIDGE RD. CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP DATE OF NAME CHANGE: 20050404 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP DATE OF NAME CHANGE: 20011116 FORMER COMPANY: FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD DATE OF NAME CHANGE: 19980213 3 1 wf-form3_155243270986430.xml FORM 3 X0206 3 2019-03-08 0 0001055726 INOVIO PHARMACEUTICALS, INC. INO 0001770390 Humeau Laurent C/O INOVIO PHARMACEUTICALS, INC. 6769 MESA RIDGE RD. SAN DIEGO CA 92121 0 1 0 0 Chief Scientific Officer Common Stock 22201 D Restricted Stock Unit 2029-03-08 Common Stock 2666.0 D Restricted Stock Unit 2027-03-10 Common Stock 5624.0 D Restricted Stock Unit 2028-03-05 Common Stock 53133.0 D Common Stock Option 10.0 2024-01-06 Common Stock 20000.0 D Common Stock Option 7.56 2025-03-05 Common Stock 25000.0 D Common Stock Option 7.02 2026-03-09 Common Stock 18000.0 D Common Stock Option 6.68 2027-03-10 Common Stock 13750.0 D Common Stock Option 4.29 2018-03-05 Common Stock 126500.0 D Each restricted stock unit represents a contingent right to receive one share of common stock. The 2,666 restricted stock vested on March 9, 2019. Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,624 restricted stock units is as follows: 2,812 shares vested on March 10, 2019; 2,812 shares will vest on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,133 restricted stock units is as follows: 26,567 shares will vest on March 5, 2020; 26,566 shares will vest on March 5, 2021. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. The common stock options will vest over a period of three years, with 25% of the shares underlying the option vesting immediately, and 25% on the first, second, and third anniversaries of the date of grant. The expiration date of this option reported in the table is the day of the tenth anniversary of the grant date of the option. /s/ Laurent Humeau 2019-03-12